Neuren Pharmaceuticals Limited carries a market capitalization of 2.08B, placing it among publicly traded companies globally.
| Market Cap | 2.08B |
| Enterprise Value | N/A |
Neuren Pharmaceuticals Limited's stock has gained approximately 16.97575% over the past 52 weeks. The 50-day moving average sits at 13.55, while the 200-day moving average is 15.98.
| Beta (5Y) | N/A |
| 52-Week Price Change | 16.97575% |
| 50-Day Moving Average | 13.55 |
| 200-Day Moving Average | 15.98 |
| Average Volume (20 Days) | N/A |
Neuren Pharmaceuticals Limited's most recent stock split took place on November 21, 2017 with a 20:1 split ratio.
| Last Split Date | 11/21/2017 |
| Split Ratio | 20:1 |